THE Pharmaceutical Society of
Australia has opened availability of
its new protocol for dealing with the
rescheduling of chloramphenicol
(PD Tue) to all pharmacists - not
just PSA members.
The protocol is related to the 01
May move of chloramphenicol to
S3 and was released to PSA
members only earlier this week.
“But due to the importance of the
protocol in patient care, it has been
decided to make it available to all
pharmacists on the PSA public
website,” said PSA national
president, Warwick Plunkett.
“Overwhelmingly this protocol
has been praised as a very useful
reference for pharmacists and
members felt there was a public
service in making it more widely
available,” he said.
It’s now online at www.psa.org.au.The above article was sent to subscribers in Pharmacy Daily's issue from 22 Apr 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Apr 10
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.